Filing Details
- Accession Number:
- 0001179110-18-012085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-09 14:14:22
- Reporting Period:
- 2018-10-05
- Accepted Time:
- 2018-10-09 14:14:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235007 | Endocyte Inc | ECYT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1509669 | S Philip Low | 3000 Kent Ave, Suite A1-100 West Lafayette IN 47906 | Chief Science Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-09-07 | 294 | $0.00 | 325,745 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2018-10-05 | 5,928 | $15.56 | 319,817 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 184,985 | Indirect | By spouse trust |
Footnotes
- Represents the sale of 5,928 shares in multiple transactions ranging in price from $15.1400 to $15.9200, resulting in a weighted-average price of $15.5597. The 5,928 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 20,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.
Billionaire Hedge Funds
